GBT Earnings & Forecasts - Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD84,570.14+0.08%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

GBT

GBTNasdaq Private Market

Private market price is not available

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

GBT Earnings & Forecasts - Benzinga

GBT Earnings & Forecasts

GBT (GBT) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

GBT Guidance

Recent Earnings Results

Metric	Q2 '22	Q1 '22	Q4 '21	Q3 '21
Earnings Per Share (Non-GAAP)
Estimate	$-1.18	$-1.30	$-1.13	$-1.11
Actual	$-1.26	$-1.26	$-1.36	$-1.13
Surprise	-6.78%	+3.08%	-20.3%	-1.80%
Revenue
Estimate	$64.4M	$56.1M	$55.4M	$53.7M
Actual	$71.5M	$55.2M	$56.1M	$52.1M
Surprise	+11.1%	-1.75%	+1.19%	-3.07%

Earnings & Guidance News

Global Blood Therapeutics's Return On Capital Employed Overview

Benzinga Pro data, Global Blood Therapeutics (NASDAQ:GBT) reported Q2 sales of $71.55 million. Earnings fell to a loss of $82.47 million, resulting in a 1.29% decrease from last quarter.

Benzinga Insights

Global Blood Therapeutics's Return On Capital Employed Overview

Global Blood Therapeutics (NASDAQ:GBT) brought in sales totaling $71.55 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 1.29%, resulting in a loss of $82.47 million.

Benzinga Insights

Global Blood Therapeutics: Q2 Earnings Insights

Global Blood Therapeutics (NASDAQ:GBT) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga Insights

PRO
Cabot Corporation Narrows Guidance

Benzinga Newsdesk

Earnings Scheduled For August 8, 2022

Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.

Benzinga Insights

A Preview Of Global Blood Therapeutics's Earnings

Global Blood Therapeutics (NASDAQ:GBT) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Global Blood Therapeutics will report an earnings per share (EPS) of $-1.18.

Benzinga Insights

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q2	Aug 8, 2022	$-1.26	$-1.18	-6.78 %
Q1	May 4, 2022	$-1.26	$-1.30	3.08 %
Q4	Feb 23, 2022	$-1.36	$-1.13	-20.3 %
Q3	Nov 4, 2021	$-1.13	$-1.11	-1.80 %

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q2	Aug 8, 2022	$71.55M	$64.39M	11.1 %
Q1	May 4, 2022	$55.16M	$56.14M	-1.75 %
Q4	Feb 23, 2022	$56.10M	$55.44M	1.19 %
Q3	Nov 4, 2021	$52.05M	$53.70M	-3.07 %